Jefferies Downgrades Quintiles (Q) to Hold
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Jefferies downgraded Quintiles (NYSE: Q) from Buy to Hold with a price target of $79.00 after QuintilesIMS has officially closed and will operate the full 4Q as a combined entity. The market has been supportive of the deal as the stock has risen 13.1% since the merger was announced (5/3), the firm notes.
Analyst David Windley commented, "QuintilesIMS likely sees its value-proposition realized over a handful of years. The strategic targets are inarguably significant opportunities. From our diligence, clients do not see IMS' data specifically as a game changer relative to other data sources and strategies. We move to HOLD as we believe Q is fully valued NT."
Shares of Quintiles closed at $76.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rite Aid (RAD)/Walgreens (WBA) Antitrust Concerns Doesn't Mean Deal is Dead, Says Deutsche Bank
- JPMorgan Downgrades Endo International plc (ENDP) to Neutral
- UPDATE: SunTrust Robinson Humphrey Downgrades Corporate Office Properties Trust (OFC) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Related EntitiesJefferies & Co, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!